813 related articles for article (PubMed ID: 29680948)
21. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
22. Imaging findings of hereditary renal tumors, a review of what the radiologist should know.
Czarniecki M; Gautam R; Choyke PL; Turkbey B
Eur J Radiol; 2018 Apr; 101():8-16. PubMed ID: 29571805
[TBL] [Abstract][Full Text] [Related]
23. [Hereditary renal tumor syndromes.].
Sánta F; Semjén D; Kuthi L
Orv Hetil; 2023 Mar; 164(10):363-375. PubMed ID: 36906860
[TBL] [Abstract][Full Text] [Related]
24. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers.
Muller M; Ferlicot S; Guillaud-Bataille M; Le Teuff G; Genestie C; Deveaux S; Slama A; Poulalhon N; Escudier B; Albiges L; Soufir N; Avril MF; Gardie B; Saldana C; Allory Y; Gimenez-Roqueplo AP; Bressac-de Paillerets B; Richard S; Benusiglio PR
Clin Genet; 2017 Dec; 92(6):606-615. PubMed ID: 28300276
[TBL] [Abstract][Full Text] [Related]
25. Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
Trpkov K; Hes O; Agaimy A; Bonert M; Martinek P; Magi-Galluzzi C; Kristiansen G; Lüders C; Nesi G; Compérat E; Sibony M; Berney DM; Mehra R; Brimo F; Hartmann A; Husain A; Frizzell N; Hills K; Maclean F; Srinivasan B; Gill AJ
Am J Surg Pathol; 2016 Jul; 40(7):865-75. PubMed ID: 26900816
[TBL] [Abstract][Full Text] [Related]
26. Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree.
Choi G; Kimonis V; Hall K; Lau WL
Am J Med Sci; 2020 Dec; 360(6):724-727. PubMed ID: 32703534
[TBL] [Abstract][Full Text] [Related]
27. Kidney cancer: Links between hereditary syndromes and sporadic tumorigenesis.
Alchoueiry M; Cornejo K; Henske EP
Semin Diagn Pathol; 2024 Jan; 41(1):1-7. PubMed ID: 38008653
[TBL] [Abstract][Full Text] [Related]
28. Genetic basis of cancer of the kidney: disease-specific approaches to therapy.
Linehan WM; Vasselli J; Srinivasan R; Walther MM; Merino M; Choyke P; Vocke C; Schmidt L; Isaacs JS; Glenn G; Toro J; Zbar B; Bottaro D; Neckers L
Clin Cancer Res; 2004 Sep; 10(18 Pt 2):6282S-9S. PubMed ID: 15448018
[TBL] [Abstract][Full Text] [Related]
29. [Hereditary leiomyomatosis and renal cell cancer - HLRCC/multiple cutaneous and uterine leimomyomatosis - MCUL].
Plevová P; Hladíková A; Tesařová M
Klin Onkol; 2012; 25 Suppl():S55-8. PubMed ID: 22920208
[TBL] [Abstract][Full Text] [Related]
30. Genetic kidney cancer syndromes.
Ho TH; Jonasch E
J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
[TBL] [Abstract][Full Text] [Related]
31. Hereditary kidney cancer: unique opportunity for disease-based therapy.
Linehan WM; Pinto PA; Bratslavsky G; Pfaffenroth E; Merino M; Vocke CD; Toro JR; Bottaro D; Neckers L; Schmidt LS; Srinivasan R
Cancer; 2009 May; 115(10 Suppl):2252-61. PubMed ID: 19402075
[TBL] [Abstract][Full Text] [Related]
32. Clear cell and papillary renal cell carcinomas in hereditary papillary renal cell carcinoma (HPRCC) syndrome: a case report.
Ferlicot S; Just PA; Compérat E; Rouleau E; Tissier F; Vaessen C; Richard S
Diagn Pathol; 2021 Nov; 16(1):107. PubMed ID: 34801057
[TBL] [Abstract][Full Text] [Related]
33. Diseases of Hereditary Renal Cell Cancers.
Iliopoulos O
Urol Clin North Am; 2023 May; 50(2):205-215. PubMed ID: 36948667
[TBL] [Abstract][Full Text] [Related]
34. Genetic alterations and histopathologic findings in familial renal cell carcinoma.
Hansel DE
Histol Histopathol; 2006 Apr; 21(4):437-44. PubMed ID: 16437389
[TBL] [Abstract][Full Text] [Related]
35. Inherited renal carcinomas.
Kawashima A; Young SW; Takahashi N; King BF; Atwell TD
Abdom Radiol (NY); 2016 Jun; 41(6):1066-78. PubMed ID: 27108134
[TBL] [Abstract][Full Text] [Related]
36. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature.
Hol JA; Jongmans MCJ; Littooij AS; de Krijger RR; Kuiper RP; van Harssel JJT; Mensenkamp A; Simons M; Tytgat GAM; van den Heuvel-Eibrink MM; van Grotel M
Fam Cancer; 2020 Jan; 19(1):55-63. PubMed ID: 31792767
[TBL] [Abstract][Full Text] [Related]
37. Genetic basis of bilateral renal cancer: implications for evaluation and management.
Linehan WM
J Clin Oncol; 2009 Aug; 27(23):3731-3. PubMed ID: 19597019
[No Abstract] [Full Text] [Related]
38. Kidney cancer: from genes to therapy.
Webster BR; Rompre-Brodeur A; Daneshvar M; Pahwa R; Srinivasan R
Curr Probl Cancer; 2021 Aug; 45(4):100773. PubMed ID: 34261604
[TBL] [Abstract][Full Text] [Related]
39. Familial non-VHL clear cell (conventional) renal cell carcinoma: clinical features, segregation analysis, and mutation analysis of FLCN.
Woodward ER; Ricketts C; Killick P; Gad S; Morris MR; Kavalier F; Hodgson SV; Giraud S; Bressac-de Paillerets B; Chapman C; Escudier B; Latif F; Richard S; Maher ER
Clin Cancer Res; 2008 Sep; 14(18):5925-30. PubMed ID: 18794106
[TBL] [Abstract][Full Text] [Related]
40. Recognizing Hereditary Renal Cancers Through the Microscope: A Pathology Update.
Peng YC; Chen YB
Surg Pathol Clin; 2018 Dec; 11(4):725-737. PubMed ID: 30447838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
